RE:Gift Francine,
you have been here the longest and know CAPRE and ACST better than anyone else.
All I know is CAPRE works wonders (based on the data I have analyzed in depth) and you don't need to take it with fatty foods like VASCEPA. For high TG patients, it performs leaps and bounds better than Vascepa.
It will help improve the lives of millions with high TG and the fact that you don't need to combine it with fatty foods for absorbption is a huge huge huge plus. People don't want to have fish or a bowl of cashews and nuts for every breakfast and take Vascepa. It's silly. They would rather take CAPRE with water or yogourt and been done with.
CAPRE also has the diabetic hidden angle and news soon to be released on its anti-inflammatory effects for COVID patients on the brink of going into the ICU. This will be BIG.
We have a blockbuster drug here and Trilogy 2 combined with the pooled 1 data will bring this to NDA. Company is telling us in between the lines to be ready.
At the end, who knows what happened with the placebo as some of the sites from Trilogy 1. Maybe the doctors did not choose the patients carefully or maybe the patients were borderline TG candidates and went on a strict diet and exercise regime on doctor's orders. Unless the FDA wants to approve cornstarch to address high TG, I think they even realize the absurdity here by looking at the rest of the data, that's why they are working with ACST to get this done.
Plus CAPRE won't go generic. It's propritery.